PBDE: Structure-activity studies for the inhibition of hepatitis c virus ns3 helicase

Molecules

Volumn 19, Issue 4, 2014, Pages 4006-4020

  Salam, Kazi Abdus ^a   Furuta, Atsushi ^b,c   Noda, Naohiro ^b,c   Tsuneda, Satoshi ^b   Sekiguchi, Yuji ^c   Yamashita, Atsuya ^d   Moriishi, Kohji ^d   Nakakoshi, Masamichi ^e   Tani, Hidenori ^c   Roy, Sona Rani ^f   Tanaka, Junichi ^f   Tsubuki, Masayoshi ^g   Akimitsu, Nobuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f UNIVERSITY OF THE RYUKYUS   (Japan)

^g HOSHI UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Marine sponge; NS3 RNA helicase; Polybrominated diphenyl ether

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTIVIRUS AGENT; DIPHENYL ETHER DERIVATIVE; ENZYME INHIBITOR; NS3 PROTEIN, HEPATITIS C VIRUS; RNA HELICASE; VIRUS PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYMOLOGY; HEPACIVIRUS; HUMAN; ISOLATION AND PURIFICATION; SPONGE (PORIFERA); STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIVIRAL AGENTS; ENZYME INHIBITORS; HALOGENATED DIPHENYL ETHERS; HEPACIVIRUS; HUMANS; PORIFERA; RNA HELICASES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84899504908     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19044006     Document Type: Article

References (27)

1. Choo, Q.L.; Kuo, G.; Weiner, A.J.; Overby, L.R.; Bradley, D.W.; Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244, 359-362.
2. Gravitz, L. Introduction: A smouldering public-health crisis. Nature 2011, 474, S2-S4.
3. Poordad, F.; McCone, J., Jr.; Bacon, B.R.; Bruno, S.; Manns, M.P.; Sulkowski, M.S.; Jacobson, I.M.; Reddy, K.R.; Goodman, Z.D.; Boparai, N.; et al. Boceprevir for untreated chronic HCV genotype 1 infection. N. Engl. J. Med. 2011, 364, 1195-1206.
4. Bacon, B.R.; Gordon, S.C.; Lawitz, E.; Marcellin, P.; Vierling, J.M.; Zeuzem, S.; Poordad, F.; Goodman, Z.D.; Sings, H.L.; Boparai, N.; et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N. Engl. J. Med. 2011, 364, 1207-1217.
5. Jacobson, I.M.; McHutchison, J.G.; Dusheiko, G.; di bisceglie, A.M.; Reddy, K.R.; Bzowej, N.H.; Marcellin, P.; Muir, A.J.; Ferenci, P.; Flisiak, R.; et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N. Engl. J. Med. 2011, 364, 2405-2416.
6. Zeuzem, S.; Andreone, P.; Pol, S.; Lawitz, E.; Diago, M.; Roberts, S.; Focaccia, R.; Younossi, Z.; Foster, G.R.; Horban, A.; et al. Telaprevir for retreatment of HCV infection. N. Engl. J. Med. 2011, 364, 2417-2428.
7. Takamizawa, A.; Mori, C.; Fuke, I.; Manabe, S.; Murakami, S.; Fujita, J.; Onishi, E.; Anodoh, T.; Yoshida, I.; Oakayama, H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 1991, 65, 1105-1113.
8. Kai, L. Development of novel antiviral therapies for hepatitis C virus. Virol. Sin. 2010, 25, 246-266.
9. Moradpour, D.; Penin F.; Rice, C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007, 5, 453-463.
10. Rice, C.M. New insights into HCV replication: Potential antiviral targets. Top. Antivir. Med. 2011, 19, 117-120.
11. De Francesco, R.; Steinkühler, C. Structure and function of the hepatitis C virus NS3-NS4A serine proteinase. Curr. Top. Microbiol. Immunol. 2000, 242, 149-169.
12. Raney, K.D.; Sharma, S.D.; Moustafa, I.M.; Cameron, C.E. Hepatitis C virus non-structural protein 3 (HCV NS3): A multifunctional antiviral target. J. Biol. Chem. 2010, 285, 22725-22731.
13. Ghany, M.G.; Nelson, D.R.; Strader, D.B.; Thomas, D.L.; Seeff, L.B. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011, 54, 1433-1444.
14. Hanif, N.; Tanaka, J.; Setiawan, A.; Trianto, A.; de Voogd, N.J.; Murni, A.; Tanaka, C.; Higa, T. Polybrominated diphenyl ethers from the Indonesian sponge Lamellodysidea. herbacea. J. Nat. Prod. 2007, 70, 432-435.
15. Sharma, G.M.; Vig, B. Studies on the antimicrobial substances of sponges. Structures of two antibacterial substances isolated from the marine sponge Dysidea. Herbacea. Tetrahedron Lett. 1972, 17, 1715-1718.
16. Salva, J.; Faulkner, D.J. A new brominated diphenyl ether from a Philippine Dysidea. species. J. Nat. Prod. 1990, 53, 757-760.
17. Handayani, D.; Edrada, R.A.; Proksch, P.; Wray, V.; Witte, L.; van Soest, R.W.; Kunzmann, A.; Soedarsono. Four new bioactive polybrominated diphenyl ethers of the sponge Dysidea. herbacea from West Sumatra, Indonesia. J. Nat. Prod. 1997, 60, 1313-1316.
18. Sionov, E.; Roth, D.; Sandovsky-Losica, H.; Kashman, Y.; Rudi, A.; Chill, L.; Berdicevsky, I.; Segal, E. Antifungal effect and possible mode of activity of a compound from the marine sponge Dysidea. herbacea. J. Infect. 2005, 50, 453-460.
19. Hattori, T.; Konno, A.; Adachi, K.; Shizuri, Y. Four new bioactive bromophenols from the palauan Sponge Phyllospongia. dendyi. Fish. Sci. 2001, 67, 899-903.
20. Fu, X.; Schmitz, F.J.; Govindan, M.; Abbas, S.A.; Hanson, K.M.; Horton, P.A.; Crews, P.; Laney, M.; Schatzman, R.C. Enzyme inhibitors: New and known polybrominated phenols and diphenyl ethers from four Indo-pacific Dysidea. sponges. J. Nat. Prod. 1995, 58, 1384-1391.
21. Liu, H.; Namikoshi, M.; Meguro, S.; Nagai, H.; Kobayashi, H.; Yao, X. Isolation and characterization of polybrominated diphenyl ethers as inhibitors of microtubule assembly from the marine sponge Phyllospongia. dendyi collected at Palau. J. Nat. Prod. 2004, 67, 472-474.
22. Xu, Y.; Johnson, R.K.; Hecht, S.M. Polybrominated diphenyl ethers from a sponge of the Dysidea. genus that inhibit Tie2 kinase. Bioorg. Med. Chem. 2005, 13, 657-659.
23. Tani, H.; Fujita, O.; Furuta, A.; Matsuda, Y.; Miyata, R.; Akimitsu, N.; Tanaka, J.; Tsuneda, S.; Sekiguchi, Y.; Noda, N. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro. Biochem. Biophys. Res. Commun. 2010, 393, 131-136.
24. Suzich, J.A.; Tamura, J.K.; Palmer-Hill, F.; Warrener, P.; Grakoui, A.; Rice, CM.; Feinstone, S.M.; Collett, M.S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 1993, 67, 6152-6158.
25. Capon, R.; Ghisalberti, E.L.; Jefferies, P.R.; Skelton, B.W.; White, A.H. Structural studies of halogenated diphenyl ethers from a marine sponge. J. Chem. Soc. Perkin Trans. 1. 1981, 2464-2467.
26. Salam, K.A.; Furuta, A.; Noda, N.; Tsuneda, S.; Sekiguchi, Y.; Yamashita, A.; Moriishi, K.; Nakakoshi, M.; Tsubuki, M.; Tani, H.; et al. Inhibition of hepatitis C virus NS3 helicase by manoalide. J. Nat. Prod. 2012, 75, 650-654.
27. Yokota, T.; Sakamoto, N.; Enomoto, N.; Tanabe, Y.; Miyagishi, M.; Maekawa, S.; Yi, L.; Kurosaki, M.; Taira, K.; Watanabe, M.; et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 2003, 4, 602-608.